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Abstract
Background: Viola yedoensis (VY, Violaceae) is a popular medicinal herb used in traditional eastern medicine for
treating lots of diseases, including inflammation and its related symptoms. However, the anti-inflammatory
properties of VY have not been demonstrated. In the present study, we investigated the anti-inflammatory effects
of VY ethanol extract (VYE) on macrophages and attempted to identify the bioactive components of VYE.
Methods: We assessed the effects of VYE on secretion of nitric oxide (NO) and inflammatory cytokines such as
tumor necrosis factor (TNF)-α, interleukin (IL)-6, and IL-1β. In addition, we explored the expression of inducible nitric
oxide synthase (iNOS), cyclooxygenase (COX)-2, and changes in heme oxygenase (HO)-1, nuclear factor (NF)-kB,
and mitogen-activated protein kinase (MAPK) signaling pathways in RAW 264.7 macrophages stimulated by
lipopolysaccharide (LPS). In addition, a rapid and useful approach to identify potential bioactive components in
VYE with anti-inflammatory effects was developed using murine macrophage cell extraction coupled with
high-performance liquid chromatography tandem mass spectrometry (LC-MS).
Results: We found that VYE exerted anti-inflammatory activity by inhibiting the production of key inflammation
mediators and related products, as well as suppression of HO-1, NF-kB, and MAPK signaling pathway activation in
RAW 264.7 cells. In addition, we identified two compounds in VYE via the cell extraction method.
Conclusions: Our results revealed that VYE exerts anti-inflammatory activities and its detailed inhibitory
mechanism in macrophages. Furthermore, we identified bioactive components of VYE.
Keywords: Viola yedoensis ethanol extract, Nuclear factor-kappaB, Mitogen-activated protein kinase, Heme
oxygenase-1, Cell extraction, Bio-active components
Background
VY is one of the traditional medicinal herb that belongs to
the violet family of Violaceae, called “Hojebigot” in Korea.
The dried aerial component of VY is Viola Herba, and is
produced in the southern regions of Korea, China, and
Japan. VY is a well-known herb in traditional oriental
medicine used for the treatment of inflammation-related
diseases including swelling, sores, boils, furuncles,
carbuncles, snakebites, and acute and chronic hepatitis
[1]. Recent studies have shown that VY has biological
activities and pharmacological functions such as anti-HIV,
anti-coagulant activities, and protective effects against
LPS-induced acute lung injury in mice [2–4]. However,
the detailed molecular mechanism of the anti-
inflammatory effects of VY is not well-characterized.
Inflammation is a first host immune response to protect
the body from injury or infection. Normal inflammatory
reactions are self-limited by down regulating pro-
inflammatory proteins and increasing anti-inflammatory
mediators [5, 6]. The onset of chronic diseases—such as
inflammatory arthritis, vascular diseases, and cancer—is
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closely associated with uncontrolled inflammatory re-
sponses or overproduction of inflammatory mediators [7].
Macrophages play a crucial role during inflammation
by regulating immune responses. Macrophages activated
by various stimulants can generate a broad array of pro-
inflammatory mediators, such as NO, iNOS, COX-2,
TNF-α, IL-6, and IL-1β [8–10]. Inflammatory cytokine
production and release in response to LPS is mediated
by the activation of NF-kB and MAPK in macrophages
[11, 12]. NF-kB and MAPKs are typical inflammatory
signaling pathways in macrophages. These two path-
ways induce pro-inflammatory cytokines and release a
wide range of inflammatory mediators. Therefore, the
majority of targets for the development of therapeutic
approaches to treat various inflammatory diseases are
associated with inhibition of these pathways.
In an unstimulated state, p65 of NF-kB is sequestered
by inhibitors of NF-kB alpha (IkBα) in the cytoplasm.
Activation of NF-kB by inflammatory stimulants, such
as LPS, occurs via phosphorylation and degradation of
IkBα. Phosphorylated IkBα is dissociated from the p65/
IkBα complex and free NF-kB translocates into the
nucleus [13], where it regulates several genes important
for immunity, including iNOS, COX-2, and certain cyto-
kines [14–16]. MAPK consists of extracellular signal-
regulated kinase (ERK), Jun NH2-terminal kinase (JNK),
and p38. MAPKs play a critical role in delivering inflam-
matory signals from the extracellular region to the intra-
cellular region or nucleus [17]. MAPK is activated by
phosphorylation of its component pathways to thereafter
activate the NF-kB pathway and iNOS gene expression.
NO is synthesized from L-arginine by iNOS, whose
expression is closely associated with the induction of
HO-1. HO-1 is also one of the important regulator of
inflammation and has exhibited an essential role in pro-
tecting the body from inflammatory processes [18]. Upon
activated macrophages, HO-1 and carbon monoxide (CO)
have been revealed to exert anti-inflammatory effects
through decrease the expression of pro-inflammatory
mediators including NO, PGE2 and cytokines [19, 20].
Thus, enhanced the production of HO-1 expression may
result in increased a lot of therapeutic agents.
To screening a bioactive components in a conven-
tional procedures, it have been performed through a
complex process, including isolating and purification of
ingredient from natural products. Modern pharmaco-
logical researches have been investigated the potential
biological activity of natural resources using the several
new techniques, such as cell membrane chromatog-
raphy, biomembrane affinity chromatography and cell
extraction coupled with analytical techniques. We pro-
posed a method of cell extraction coupled with LC-MS
analysis to screen for bioactive components using mac-
rophages. These techniques involve direct treatment of
the natural products in the cells, incubation for 24 h to
allow the bioactive components to selectively combine
with specific receptors and/or channels and/or enzymes
on the cell membrane or inside cells, extraction with
70 % acetonitrile, and detection of the cell-combining
components by LC-MS analysis. Recently, these methods
were employed for screening of single compounds or
drug candidates from natural resources used in trad-
itional medicine [21, 22].
In present study, we examined the anti-inflammatory
effects of VYE on LPS-induced inflammation in RAW
264.7 and mouse primary macrophage cells. In addition,
we evaluated whether VYE regulates NF-kB, MAPK, and
HO-1 pathways to demonstrate its inhibitory mechanism
underlying its anti-inflammatory effect. Furthermore, we




VY was obtained as a dried herb from Yeongcheonhyundai
Herbal Market (Yeongcheon, Korea) and verificated by
Prof. KiHwan Bae (Chungnam National University,
Daejeon, Korea). The voucher specimen of VY was
stored in the herbarium of KM-Application Center,
Korea Institute of Oriental Medicine. The pulverized
plant (30.0 g) was extracted with 390 mL of 70 % etha-
nol at 40 °C in a shaking incubator (100 rpm) for 24 h.
After extraction, the solution was filtered using 185-
mm filter paper (Whatman, Piscataway, NJ, USA) and
enrichmented using a rotary vacuum evaporator (Buchi,
Tokyo, Japan). Samples were then freeze-dried and
maintained in desiccators at −20 °C before use. The
yield of VYE was 11.25 %.
Materials and reagents
Roswell Park Memorial Institute (RPMI) 1640 medium,
antibiotics, and fetal bovine serum (FBS) were obtained
from Hyclone (Logan, UT, USA). All cell culture dishes
and plates were obtained from SPL life sciences (Pocheon,
Korea). LPS, dexamethasone, bovine serum albumin
(BSA), cell counting kit (CCK), and enzyme-linked im-
munosorbent assay (ELISA) antibody sets were obtained
from Sigma (St. Louis, MO, USA), Dojindo (Kumamoto,
Japan), and eBioscience (San diego, CA, USA), respect-
ively. Various primary antibodies for Western blot analysis
were purchased from Cell Signaling Technology (Boston,
MA, USA). Horseradish peroxidase (HRP)-conjugated
secondary antibodies were obtained from Thermo Scien-
tific (Rockford, IL, USA). An extraction kit for RNA isola-
tion was purchased from iNtRON (Sungnam, Korea).
DNA synthesis kits, oligonucleotide primers, and Accu-
Power® 2X Greenstar qPCR Master Mix (ROX) were
obtained from Bioneer (Daejeon, Korea).
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Macrophage cell culture and treatment of test drug
The murine macrophage RAW 264.7 was obtained from
the American Type Culture Collection (ATCC, Manassas,
VA, USA) and maintained in RPMI 1640 (contained
10 % FBS and antibiotics). Cells were then incubated
in humidified 5 % CO2 atmosphere at 37 °C. To
stimulate the inflammatory signals of macrophages,
the RPMI 1640 medium was exchanged for fresh
medium and 200 ng/mL of LPS was added in the
presence or absence of VYE (10, 30, 50, 100 and
150 μg/mL) for the indicated periods.
Isolation of mouse peritoneal macrophage and cell
culture
Male BALB/c mice (25 ± 3 g) were obtained from
SamtakoBioKorea (Osan, Korea). 300 μL of sterilized
3 % sodium thioglycollate (Sigma, St. Louis, MO,
USA) was injected to abdominal cavity of mice. All mice
were housed at 5 per cage at room temperature (RT)
under a 12-h: 12-h light/dark cycle. After three days, the
mice were killed and peritoneal macrophages were col-
lected by washing peritoneal cavity with 10 mL (per each
mouse) of ice-cold phosphate-buffered saline (PBS). The
cells were centrifuged at 2000 rpm for 5 min at 4 °C and
the supernatant containing red blood cell (RBC) debris
was discarded. The cell pellet was resuspended in com-
pleted RPMI 1640 and incubated for 18 h for attachment
to the culture plate [23]. To stimulate the cells, the
medium was exchanged for fresh RPMI 1640 and LPS was
added in the presence or absence of VYE for 24 h. Animal
study was performed according to the Guide for the Ani-
mal Care and Use Committee of the Korea Institute of
Oriental Medicine (reference numbers: 14–079).
Cell viability assays
RAW 264.7 macrophages were mechanically scraped
and plated into 96 well culture plates (5 × 104 cells/well).
After 18 h, five concentrations of VYE were added to
the cells and incubated for 24 h. CCK solutions (10 μL)
were applied to each well. Then the cells were incubated
for a further 1 h. The optical density value was readed at
450 nm using an ELISA reader (infinite M200, Tecan,
Männedorf, Switzerland).
Measurement of NO production
To measure secretion of NO, cells were plated into 96
well culture plates (5 × 104 cells/well). After 18 h, cells
were treated with VYE and stimulated using LPS for
24 h. Griess reagent (1 % sulfanilamide, 0.1 % N-1-
napthylethylenediamine dihydrochloride, and 2.5 %
phosphoric acid) was added to each well and further
incubated at RT for 5 min [24]. Absorbance at 570 nm
was determined using the ELISA reader.
Determination of inflammatory cytokines
To explore the inhibitory effects of VYE on cytokine
production in macrophages upon LPS stimulation, the
secretion of TNF-α, IL-6, and IL-1β was measured using
an ELISA antibody set. Macrophages were grown in 24
well culture plates (5 × 104 cells/well). The cells were
pretreated with VYE for 1 h and then challenged with
LPS for another 24 h. The supernatants were then centri-
fuged at 13000 rpm at 4 °C for 5 min for discarded cell
debris. The levels of cytokine were analyzed using
ELISA antibody sets, according to protocol of
manufacturer.
Preparation of whole cell, cytoplasmic and nuclear
fractions
To measure protein expression, cells were stimulated by
LPS treatment in the presence or absence of VYE for the
indicated periods (30 min–24 h). After incubation with
VYE and/or LPS, cells were collected and resuspended in
radio immunoprecipitation assay (RIPA) buffer (Millipore,
Bedford, MA, USA) containing inhibitor cocktail (protease
and phosphatase inhibitor) to get whole cell lysates. Cyto-
plasmic and nuclear lysates were isolated by NE-PER
nuclear and cytoplasmic extraction reagents (Thermo
Scientific, Rockford, IL, USA) according to protocol of
manufacturer.
Western blot analysis
Total proteins of whole cell lysates or cytoplasmic and
nuclear extracts were assayed using Bradford’s reagent
(Bio-Rad Hercules, CA, USA). The proteins were divided
using sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis (SDS-PAGE) and transferred to a nitrocellulose
Table 1 Primers used for real-time RT-PCR analysis















F forward, R reverse
Jeong et al. BMC Complementary and Alternative Medicine  (2016) 16:180 Page 3 of 16
Fig. 1 a Cytotoxicity of VYE in RAW 264.7 macrophages and the suppressive effect of VYE on (b) NO secretion and (c–e) TNF-α, IL-6, and IL-1β
cytokine production upon LPS stimulation. RAW 264.7 cells were pretreated with VYE for 1 h prior to incubation with LPS for 24 h. Cytotoxicity
was determined by CCK assay. NO content in the conditioned medium was determined using Griess reagent. TNF-α, IL-6, and IL-1β levels in the
medium, as measured by ELISA. As a control, cells were incubated with vehicle alone. Data represent the means ± SE of three independent experiments. **
p< 0.001 compared to the LPS-stimulated value
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(NC) membrane (Millipore, Bedford, MA, USA). After
blocking of nonspecific sites with 3 % BSA, the mem-
branes were incubated with each primary antibodies at
RT 2 h or 4 °C overnight. The membranes were subse-
quently incubated with HRP-conjugated anti-mouse or
anti-rabbit secondary antibodies. The signals were
detected using Super Signal West Femto chemilumines-
cent substrate (Thermo Scientific, Rockford, IL, USA).
Total RNA extraction and real-time reverse transcription-
polymerase chain reaction (real-time RT-PCR)
Total cellular RNA was extracted by easy-BLUE™ RNA
extraction kit (iNtRON Biotech, Daejeon, Korea) in
accordance with the protocol of manufacturer. cDNA
was synthesized from 1 μg of total RNA using AccuPo-
wer®CycleScript RT PreMix (Bioneer, Daejeon, Korea).
The oligonucleotide primers for real-time RT-PCR are
indicated in Table 1 [25]. The samples were setup in
triplicate in a 20 μL total volume: 0.3 μM final concen-
trations of each primer (1 μL of forward and reverse pri-
mer), 10 μL of AccuPower® 2X Greenstar qPCR Master
Mix (Bioneer, Daejeon, Korea), 3 μL of 0.1 % DEPC-
treated water, and 5 μL of template DNA. The following
PCR conditions were applied: TNF-α, IL-6, IL-1β, iNOS,
COX-2, HO-1, and β-actin, with 40 cycles of 94 °C for
15 s and 60 °C for 1 min [25]. The amplification and ana-
lysis were performed by a QuantStudio 6 Flex Real-time
PCR System (Thermo Scientific, Rockford, IL, USA). Sam-
ples were compared by the relative CT method. The re-
sults of real-time RT-PCR were presented as inflammatory
mediator gene induction fold, which were calculated using
β-actin as an internal control.
Cell extraction
RAW 264.7 cells were seeded into 100-mm culture dishes
at a density of 1.0 × 106 cells/mL, grown in completed
RPMI medium, and maintained at 37 °C in an atmosphere
of 5 % CO2 for 18 h. The culture medium was discarded,
and serum-free RPMI medium and VYE (at a final con-
centration of 150 μg/mL) were added, followed by incuba-
tion for 24 h. The cells were then harvested and
centrifuged at 2000 rpm for 5 min, after which the depos-
ited cells were washed five times with PBS to remove
uncombined components. Finally, the deposited cells were
extracted with 1 mL of 70 % acetonitrile by ultrasonic
extraction for 1 h. After centrifugation at 13,000 rpm for
10 min, the obtained supernatant was filtered through
0.45 μm nylon membranes for LC-MS analysis.
The application of HPLC coupled with Q-TOF mass
spectrometry
Agilent 1260 series (Agilent, Santa Clara, CA, USA) was
used for chromatography analysis with an online degasser,
a binary pump, an auto plate-sampler, a thermostatically
Fig. 2 Effect of VYE on LPS-induced (a) TNF-α, (b) IL-6, and (c) IL-1β
mRNA expression in macrophages. Cells were pretreated with VYE for
1 h and stimulated with LPS for a further 6 h. mRNA levels were
analyzed by real-time RT-PCR. Amplification and analyses of mRNA
were performed using the QuantStudio 6 Flex Real-time PCR System
(Thermo Scientific, Rockford, IL, USA). Data represent the means ± SE of
three independent experiments. * p < 0.01 and ** p < 0.001 compared
to the LPS-stimulated value
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controlled column compartment, and a UV detector.
Chromatographic separation was achieved on an Shiseido
CapCell PAK C18 column (150 × 4.6 mm, 5 μm) by gradi-
ent elution of a mixture of water (solvent A) and aceto-
nitrile (solvent B) containing 0.1 % formic acid at a flow
rate 0.6 mL/min. The gradient elution system was as
below: 0–5 min, 15 % B; 5–30 min, 15–95 % B. A tandem
quadrupole time-of-flight (Q-TOF) mass spectrometery
was performed on an Agilent 6530 Q-TOF mass spec-
trometer (Agilent, Santa Clara, CA, USA). The acquisition
parameters were set as follows. The analysis was operated
in negative ion mode with an electrospray ionization (ESI)
interface. The nebulizer pressure was set to 40 psi. The
voltages of capillary, fragmentor, and skimmer were set to
4000 V, 175 V, and 65 V, respectively. The gas used for
both drying and sheath was nitrogen. The temperature
and flow rate of gas for each process were 325 °C; 10.0 L/
min and 350 °C; 12.0 L/min. The mass scan range was
configured from 50 to 1000m/z and all data were col-
lected in centroid mode. The accurate-mass capability of
the TOF analyzer allowed reliable confirmation of the
identity of the detected metabolites, normally with mass
errors below 5 ppm in routine analysis. The MassHunter
Workstation software LC/MS Data Acquisition for 6530
series Q-TOF (version B.05.00) was used to adjust the pa-
rameters for acquiring data.
Extraction, fractionation and isolation
Dried whole plants of VY (600.0 g) were ground and ex-
tracted three times with 70 % ethanol for 90 min using
Fig. 3 Effect of VYE on (a) iNOS, COX-2 protein levels, and (b) HO-1 protein induction in RAW 264.7 cells. Cells were treated with (a) LPS alone or LPS plus
VYE for 24 h or with (b) VYE alone for 6 h. Protein levels were determined by Western blotting, as described in the Materials and Methods,
and quantitated using a Davinch-chemi™ CAS-400SM chemiluminescence imaging system (Core Bio, Seoul, Korea). β-actin served as a control.
The experiment was repeated three times independently, and similar results were obtained
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an ultrasonicator. The solvent was then evaporated
under vacuum. The residue (58.2 g) was suspended in
water and then partitioned with n-hexane, EtOAc, and
n-BuOH, successively. The n-BuOH fraction (16.5 g) was
separated into six fractions (VY 2A-2 F) on an HP-20 col-
umn chromatography using gradient elution with H2O
100 % to MeOH 100 %. According to the TLC profiles,
fraction VY-2D was re-chromatographed on RP C18
column chromatography using gradient elution with
H2O-MeOH (2:1 to 3:2) to give Compound 1 (273 mg)
and Compound 2 (226 mg). A summary of the extrac-
tion, fractionation, and isolation scheme is shown in
Fig. 9.
Compound 1; Isoschaftoside
ESI-MS m/z 563.1441 [M-H]−. 1H-NMR (600 MHz,
DMSO-d6): δ 8.03 (2H, d, J = 8.5 Hz, H-2′ and H-6′),
6.92 (2H, d, J = 8.5 Hz, H-3′ and H-5′), 6.82 (1H, s,
H-3), 4.76 (1H, d, J = 9.5 Hz, Glc-H-1), 4.72 (1H, d, J =
9.8 Hz, Ara-H-1), 3.25–3.90 (9H, m, Ara-H-2-5 and Glc-
H-2-6) ppm. 13C-NMR (150 MHz, DMSO-d6):δ 61.3
(Glc-C-6), 68.5 (Ara-C-4), 69.6 (Ara-C-2), 70.2 (Ara-C-
5), 70.6 (Glc-C-4), 71.0 (Gla-C-2), 73.3 (Glc-C-1), 73.9
(Ara-C-3), 74.2 (Ara-C-1), 78.9 (Glc-C-3), 81.9 (Glc-C-
5), 102.6 (C-3), 103.7 (C-10), 105.8 (C-8), 108.1 (C-6),
116.0 (C-3′ and C-5′), 121.2 (C-1′), 129.1 (C-2′ and
C-6′), 155.1 (C-9), 158.3 (C-5), 161.1 (C-7), 161.3 (C-4′),
164.1 (C-2), 182.4 (C-4) ppm.
Compound 2; Apigenin 6, 8-di-C-α-L-arabinopyranoside
ESI-MSm/z 533.1363 [M-H]−. 1H-NMR (600 MHz,
DMSO-d6): δ 8.02 (2H, d, J = 8.4 Hz, H-2′ and H-6′),
6.91 (2H, d, J = 8.4 Hz, H-3′ and H-5′), 6.83 (1H, s, H-
3), 4.70 (1H, d, J = 9.5 Hz, Ara-H-1′), 4.70 (1H, d, J =
9.5 Hz, Ara-H-1″), 3.44–3.89 (10H, m, Ara-H-2′-5′ and
Ara-H-2″-5″) ppm. 13C-NMR (150 MHz, DMSO-d6):δ
182.3 (C-4), 164.2 (C-2), 161.5 (C-7), 161.2 (C-5), 161.2
(C-4′), 155.0 (C-9), 129.5 (C-2′ and C-6′), 121.1 (C-1′),
116.0 (C-3′ and C-5′), 108.3 (C-6), 104.9 (C-8), 103.4
(C-10), 102.3 (C-3), 74.1 (Ara-C-1′), 74.1 (Ara-C-1″),
74.0 (Ara-C-3′), 74.0 (Ara-C-3″), 70.2 (Ara-C-5′), 70.2
(Ara-C-5″), 69.0 (Ara-C-2′), 69.0 (Ara-C-2″), 68.6 (Ara-
C-4′), 68.6 (Ara-C-4″) ppm.
Statistical analysis test
All data are presented as means ± SD of three independ-
ent experiments unless stated otherwise. Significant dif-
ferences were determined using Student’s t-tests after
comparing each treated group to the LPS group. Each
experiment was repeated three times or more to yield
comparable results. Values of * P < 0.01 and ** P < 0.001
were considered to indicate statistical significance.
Statistical analysis software
GraphPad Prism version 5.02 software (GraphPad Soft-
ware, Inc., San Diego, CA) was used for all the statistical
analyses in this study.
Fig. 4 Effects of VYE on mRNA expression of (a) iNOS, (b) COX-2,
and (c) HO-1 in macrophages. Cells were treated with (a, b) LPS
alone or with LPS and VYE for 24 h and (c) VYE alone for 3 h. Data
represent the means ± SE of determinations from three independent
experiments. ** p < 0.001 compared to the LPS-stimulated value
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Results
Effect of VYE on cell viability and NO production in RAW
264.7 cells
To investigate the cytotoxicity of VYE in RAW 264.7
cells, we conducted viability assays using CCK. As
shown in Fig. 1a, 10 and 150 μg/mL of VYE had no ef-
fect on RAW 264.7 cell viability. Thus, to exclude the
potential influence of cytotoxicity, the concentration of
VYE was limited to 150 μg/mL in subsequent experi-
ments. Half maximal inhibitory concentration (IC50)
value of VYE on the viability of RAW 264.7 cells was
278.8 μg/mL and IC50 of dexamethasone was 390.3 μM
(data not shown). Dexamethasone, which is widely used
for the treatment of inflammation-related disease, was
used as a positive control in this study. Because NO
production is related with various inflammatory diseases,
we measured the inhibitory activity of VYE on NO pro-
duction in LPS-stimulated macrophages. The concentra-
tion of nitrite in supernatants was determined using
Griess reagent. As shown in Fig. 1b, the release of NO
was significantly inhibited by VYE pretreatment in a
concentration-dependent manner. Especially, 150 μg/mL
VYE inhibited NO production by more than 90 %.
Inhibitory activities of VYE on secretion of inflammatory
cytokines and their mRNA expression
To further analyze the potential inhibitory activity of VYE
on inflammatory cytokines (TNF-a, IL-6, and IL-1β) pro-
duction and their mRNAs expression, we used ELISA and
real-time RT-PCR. As shown in Fig. 1c, d and e, secretion
Fig. 5 Effects of VYE on LPS-induced (a) translocation of NF-kB p65 into the nucleus and (b) phosphorylation of IkBα in RAW 264.7 cells. Cells
were pretreated with VYE for 1 h and stimulated with LPS for a further (a) 1 h or (b) 30 min. β-actin and TATA box-binding protein (TBP) were
used as control proteins of the cytosolic and nuclear fractions, respectively. The experiment was repeated three times independently, and similar
results were obtained
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of IL-6 and IL-1β was significantly repressed by VYE in a
dose-dependently. However, VYE had no effect on TNF-α
secretion compared with the negative control (LPS treated
only) in this assay. Consistent with this result, expression
of TNF-α mRNA was not inhibited by treatment with
VYE at any concentration (Fig. 2a). However, VYE showed
an inhibitory activity on IL-6 and IL-1β mRNA expression
at 100 μg/mL or higher (Fig. 2b and c).
VYE strongly represses iNOS but not COX-2 upon LPS
stimulation and induces HO-1 in RAW 264.7 macrophages
To examine the mechanism by which VYE reduces NO
and cytokine production by LPS stimulation, we
evaluated the effect of VYE on iNOS, COX-2, and HO-
1 expression in RAW 264.7 macrophages. The inhibi-
tory effects of VYE on the protein and mRNA levels of
iNOS, COX-2, and HO-1 were evaluated by Western
blot analysis and real-time RT-PCR. As shown in
Fig. 3a, VYE strongly reduced protein levels of iNOS.
However, COX-2 protein expression was slightly re-
pressed at concentrations of 10–150 μg/mL. In
addition, as shown in Fig. 3b, the HO-1 protein level
was markedly augmented by VYE treatment. Consist-
ent with this result, VYE treatment significantly
repressed the expression of iNOS mRNA and induced
that of HO-1 (Fig. 4a and c). By contrast, COX-2
Fig. 6 Effects of VYE on the phosphorylation of (a) ERK, (b) p38, and (c) JNK MAPKs in LPS-stimulated macrophages. Cells were treated with VYE
for 1 h and challenged with LPS for 30 min. Proteins were examined by Western blot analysis. ERK, p38 and JNK were used as controls for their
phosphorylated forms. The experiment was repeated three times independently, and similar results were obtained
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mRNA expression was repressed by VYE treatment,
the opposite of the protein levels (Fig. 4b).
Suppressive effects of VYE on activation of NF-kB signaling
pathway in macrophages
The NF-kB is closely related to inflammatory mediator
production such as cytokines and iNOS. Therefore, we
assessed the effect of VYE on the activation of NF-kB by
analyzing nuclear translocation of p65 and IkBα phos-
phorylation. As shown in Fig. 5a, VYE significantly inhib-
ited nuclear translocation of NF-kB p65 by LPS
stimulation at all concentrations (10–150 μg/mL). We also
evaluated the effects of VYE on the phosphorylation and
degradation of IkBα upon LPS stimulation. As shown in
Fig. 5b, the activation of IkBα through phosphorylation
and degradation was reduced in a dose-dependently by
VYE treatment. These results suggested that VYE inhibits
translocation of NF-kB and phosphorylation, degradation
of IkBα.
VYE inhibits phosphorylation of MAPKs by LPS
stimulation in RAW 264.7 cells
The MAPK family members include ERK, p38, and JNK.
MAPKs are activated by stimuli such as LPS, and play
an essential role in the regulation of inflammatory medi-
ator production. We examined whether activation of
MAPKs is repressed by VYE treatment. As shown in
Fig. 6a and c, phosphorylation of ERK and JNK MAPK
by LPS treatment was markedly decreased in a dose-
dependent manner. In addition, VYE only slightly af-
fected p38 activity at concentrations of 10–100 μg/mL,
but strongly inhibited phosphorylation of p38 at the
highest dose tested (150 μg/mL) (Fig. 6b).
VYE inhibits cytokine production by LPS stimulation in
mouse peritoneal macrophages
First, we examined the anti-inflammatory activity of VYE
on RAW 264.7 cell line. Next, we confirmed the inhibitory
activity of VYE in mouse primary macrophages. We mea-
sured the levels of inflammatory cytokines—TNF-α, IL-6,
and IL-1β. As shown in Fig. 7b, VYE significantly inhibited
secretion of IL-6 in a dose-dependently. However, VYE at
concentrations of 10–100 μg/mL only slightly inhibited or
did not inhibit TNF-α and IL-1β secretion. In addition,
150 μg/mL VYE suppressed TNF-α and IL-1β production
by peritoneal macrophages (Fig. 7a and c). These results
indicated that 150 μg/mL VYE effectively inhibited the in-
flammatory response in primary macrophage cells without
toxicity (cell viability data not shown).
Screening and analyzing bioactive components
VYE, which has anti-inflammatory effects, was used
for screening bioactive candidates that interact with
RAW 264.7 cells. The compounds were screened and
Fig. 7 Effect of VYE on LPS-induced (a) TNF-α, (b) IL-6, and (c) IL-1β
cytokine production in mouse peritoneal macrophages. Mouse
peritoneal macrophage cells were treated with VYE for 1 h prior
to incubation with LPS for 24 h. Cytokine levels in the culture
supernatant were analyzed by ELISA. As a control, the cells were
incubated with vehicle alone. Data represent the means ± SE of
three independent experiments. ** p < 0.001 compared to the
LPS-stimulated value
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analyzed using HPLC-DAD-QTOF MS. The UV chro-
matograms (monitored at 330 nm) of extracts from
VYE, blank control (desorption eluate of RAW 264.7
cells incubated without VYE), fourth wash eluate of
cell extract, and desorption eluate of cells incubated
with VYE are shown in Fig. 8. The chromatogram of
VYE extract contained two major peaks at 271 and
338 nm (Fig. 8d). The chromatogram of desorption
eluate of cell extract also showed these peaks. How-
ever, the chromatogram of the blank control and
fourth wash eluate of cell extract did not. The mass
chromatograms (monitored negative mode) of extracts
from VYE, two major peaks were observed at
10.5 min (m/z 563) and 11.8 min (m/z 533) (Fig. 9d).
Each molecular ion peak at m/z 563 and 533 was
identified using the extracted ion chromatogram (EIC)
mode (Fig. 10a and b). In Fig. 10a and b, the peak
was detected only in the desorption eluate of cell ex-
tract. In other words, the interaction between compo-
nents and cells was shown to be highly selective and
strong.
Isolation and identification of the bioactive candidates
The two compounds of the n-BuOH fraction of VYE
were isolated from various open chromatography and
TLC profiles (Fig. 11). The structures of two compounds
were identified as isoschaftoside (1) [26, 27] and api-
genin 6, 8-di-C-α-L-arabinopyranoside (2) [27, 28] by
spectroscopic analysis of the HPLC-DAD-MS, 1H-NMR,
and 13C-NMR (Figs. 12 and 13 )
Compound 1
The 13C-NMR spectrum of Fig. 12 showed one carbonyl
carbon [δ 182.4], 15 aromatic carbons, and typical car-
bon signals of a glucose moiety. These carbon signals
were estimated to be flavonoid glycoside. The 1H-NMR
spectrum of Fig. 12 showed ortho coupling between δ
6.92 (2H, d, J = 8.5 Hz) and δ 8.03 (2H, d, J = 8.5 Hz) and
two anomeric protons [δ 4.72 and δ 4.76]. The molecu-
lar formula was determined to be C26H28O14 based on
the ESI-MS (m/z 563.1441 [M-H]−). Consequently, the
chemical structure of compound 1 was elucidated as api-
genin 6-C-α-L-arabinopyranosyl-8-C-β-D-glucopyranp-
side, which was named isoschaftoside.
Compound 2
The 13C-NMR spectrum of Fig. 13 contained one car-
bonyl carbon [δ 182.3], 15 aromatic carbons, and typical
carbon signals of the glucose moiety, similar to com-
pound 1. Therefore, the compound was estimated to be
flavonoid glycoside. The 1H-NMR spectrum of Fig. 13
showed ortho coupling between δ 6.91 (2H, d, J =
8.4 Hz) and δ 8.02 (2H, d, J = 8.4 Hz), and two anomeric
protons [δ 4.70]. Its molecular ion peak was at m/z
533.1363 [M-H]−in the ESI-MS. The molecular formula
was deduced as C25H26O13 on the basic
1H-, 13C-NMR,
and ESI-MS data. Thus, the chemical structure of com-
pound 2 was determined to be apigenin 6, 8-di-C-α-L-
arabinopyranoside.
Discussion
VY is an important medicinal herb in traditional medi-
cine and has been used to treat associated with
inflammation-related diseases in Korea [1]. A previous
study revealed that VY exerts anti-HIV effects [2], and
another revealed anti-coagulant activity [3]. In addition,
recent studies have shown the protective effect of VY on
LPS-induced acute lung injury in mice [4].
In our present study, we evaluated the anti-inflammatory
effect of VYE in LPS-induced RAW 264.7 cells and mouse
Fig. 8 UV chromatogram (330 nm). a Desorption eluate of RAW 264.7 cells incubated without VYE, b fourth wash eluate of cell extract, c desorption
eluate of cells incubated with VYE, and d extract of VYE
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Fig. 9 Mass chromatogram (negative mode). a Desorption eluate of RAW 264.7 cells incubated without VYE, b fourth wash eluate of cell extract,
c desorption eluate of cells incubated with VYE, and d extract of VYE
Fig. 10 (A) Extracted ion chromatogram (EIC) of VYE extract for 563 and (B) extracted ion chromatogram (EIC) of VYE extract for 533. (A)
Desorption eluate of RAW 264.7 cells incubated without VYE, (B) fourth wash eluate of cell extract, (C) desorption eluate of cells incubated with
VYE, and (D) extract of VYE
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primary macrophages. First, we investigated that VYE
treatment did not result in cytotoxicity to macrophages,
did not affect cell viability at concentrations below 150 μg/
mL. Overproduction of NO and iNOS is closely related to
lots of inflammatory diseases [29, 30]; thus, we examined
the suppress effects of VYE on NO and iNOS production
induced by LPS. We found that VYE strongly inhibited
NO secretion and repressed expression of iNOS protein
and mRNA levels, which is the synthesizing enzyme of
NO, in a concentration-dependent manner. These results
indicate that the suppressive effect of VYE on iNOS ex-
pression conduce to the inhibition of NO secretion.
The expression of NO and iNOS was due to a direct
influence on the induction of HO-1 [31], we further inves-
tigated the effect of VYE treatment on HO-1 expression.
Thus, we determined the HO-1 protein and mRNA
expression by VYE treatment absence of LPS. In our
experiments, VYE exerts strongly induced HO-1 expres-
sion dose-dependently (10–150 μg/mL) in macrophage
RAW 264.7, also the production of HO-1 influenced the
inhibitory activity of VYE on NO secretion and iNOS ex-
pression. This result about HO-1 expression suggests that
the anti-inflammatory effects of VYE is influenced not
only by a blockade of NF-kB and MAPK pathway activa-
tion but also by the induction of HO-1.
VYE inhibited the secretion of inflammatory cyto-
kines and expression of their mRNA genes, such as
IL-6 and IL-1β. The transcription factor NF-kB is an
important regulator of various genes involved in in-
flammatory responses [32]. After activation of NF-kB
by LPS, IkB bound to NF-kB in cytoplasm becomes
phosphorylated, leading to p65 translocation into the
nucleus and phosphorylation of IkBα. Thus, we
examined p65 levels in cytoplasmic and nuclear ex-
tracts by Western blotting. As a result, VYE reduced
translocation and degradation of NF-kB p65, phos-
phorylation of IkBα upon LPS stimulation in a dose-
dependent manner. These data are consistent with
previous studies that indicated that NF-kB response
elements are reveal in the promoters of the genes en-
coding iNOS and inflammatory cytokine [16, 33–35].
Since many anti-inflammatory drugs inhibit NF-kB
activation, VYE extract could represent a novel
anti-inflammatory agents.
Fig. 11 Isolation from V. yedoensis
Jeong et al. BMC Complementary and Alternative Medicine  (2016) 16:180 Page 13 of 16
MAPKs activated by LPS are associated with produc-
tion of inflammatory mediators such as iNOS expression
in RAW 264.7 cells [36], we also investigated the inhibi-
tory effect of VYE on MAPK phosphorylation. Phos-
phorylation of ERK and JNK MAPK were significantly
inhibited, but had only a minor effect on the phosphor-
ylation of p38 MAPK by VYE treatment. These results
mean that the anti-inflammatory activity of VYE on
MAPKs phosphorylation is directly involved in the in-
hibition of NF-kB activation and repression of inflamma-
tory mediator production in macrophages. In this study,
we examined whether VYE inhibits various inflamma-
tory mechanisms, such as NF-kB, MAPK, and HO-1.
We found that VYE shows strong inhibitory effects on
various signaling pathways.
We further investigated the inhibitory activity of VYE
on cytokine production in mouse peritoneal macrophages
upon LPS stimulation to confirm its anti-inflammatory
effect. Consistent with the results from cell lines, VYE sig-
nificantly inhibited the production of IL-6 cytokines in
primary cells without exerting cytotoxicity. However, it
did not inhibit TNF-α and IL-1β production, except at the
highest concentration tested (150 μg/mL). These results
suggest that VYE inhibits the inflammatory response not
only in RAW 264.7 cells but also in primary cells.
In this study, we examined the anti-inflammatory
activity and inhibitory mechanism of VYE. Numerous
assays showed that VYE inhibited the production of
inflammatory mediators including NO and pro-
inflammatory cytokines such as TNF-a, IL-6 and IL-1β,
as well as activation of the NF-kB and MAPK signaling
pathways. Moreover, expression of HO-1 was strongly
induced by VYE treatment. These results indicate that
VYE has suppressive effects on inflammatory responses.
Based on these results, we screened the potential bio-
active components of VYE in macrophages by LC-MS
and determined their chemical structure using HPLC-
DAD-MS, 1H-NMR, and 13C-NMR. We identified two
major bioactive components that could interact with
macrophages and investigated the structures of these
Fig. 12 1H- and 13C-NMR spectra of compound 1
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compounds. The chemical structure of compound 1 was
apigenin 6-C-α-arabinopyranosyl-8-C-β-D-glucopyranp-
side, called isoschaftoside. The chemical structure of com-
pound 2 was apigenin 6, 8-di-C-α-L-arabino-pyranoside.
In summary, we demonstrated the anti-inflammatory ac-
tivity and inhibitory mechanism of VYE. We also identified
two bioactive components that interact with macrophages
and determined their structures. The role in inflammation
of the two pure compounds warrants further studies.
Conclusions
In conclusion, the results of the present study demon-
strated that VYE has strong inhibitory activity on
production of inflammatory mediators including NO,
inflammatory cytokines, and iNOS in LPS-stimulated
RAW 264.7 cells. These effects are mediated by inhibit-
ing NF-kB activation through IkBα stabilization and
blocking MAPK phosphorylation. In addition, induction
of HO-1 expression by VYE involved in the inhibition
of inflammatory mediators, and VYE inhibited the
production of inflammatory cytokines in mouse primary
macrophages. Furthermore, we screened two bioactive
components and determined their chemical structure.
These results indicate VYE to have potential as an anti-
inflammatory agent.
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